Gemini Therapeutics is a precision medicine company focused on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases. Our therapeutic candidates are matched to molecular abnormalities found in patients with high clinical need and our broad multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. Launched with funding from leading life science investors and powered by academic partnerships around the world, we are developing a series of first-in-class therapeutics. For more information, visit www.GeminiTherapeutics.com
View Top Employees from Gemini TherapeuticsWebsite | http://www.geminitherapeutics.com |
Employees | 11 (11 on RocketReach) |
Founded | 2015 |
Technologies |
JavaScript,
HTML,
PHP
+32 more
(view full list)
|
Industry | Biotechnology, Biopharma, Health Care, Science and Engineering, Health Diagnostics |
Looking for a particular Gemini Therapeutics employee's phone or email?
Suresh Katti is the Senior Vice President Research of Gemini Therapeutics.
11 people are employed at Gemini Therapeutics.
Gemini Therapeutics is based in Cambridge, Massachusetts.